Cargando…
ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma
Hypoxia and angiogenesis play key roles in the pathogenesis of esophageal squamous cell carcinoma (ESCC), but regulators linking these two pathways to drive tumor progression remain elusive. Here we provide evidence of ADAM9's novel function in ESCC progression. Increasing expression of ADAM9 w...
Autores principales: | Lin, Yu-Sen, Kuo, Ting-Ting, Lo, Chia-Chien, Cheng, Wei-Chung, Chang, Wei-Chao, Tseng, Guan-Chin, Bai, Shih-Ting, Huang, Yu-Kai, Hsieh, Chih-Ying, Hsu, Han-Shui, Jiang, Yi-Fan, Lin, Chen-Yuan, Lai, Liang-Chuan, Li, Xing-Guo, Sher, Yuh-Pyng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495400/ https://www.ncbi.nlm.nih.gov/pubmed/34671207 http://dx.doi.org/10.7150/ijbs.65488 |
Ejemplares similares
-
An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases
por: Chou, Cheng-Wei, et al.
Publicado: (2020) -
ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT
por: Lin, Chen-Yuan, et al.
Publicado: (2017) -
ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis
por: Chiu, Kuo-Liang, et al.
Publicado: (2017) -
ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis
por: Chiu, Kuo-Liang, et al.
Publicado: (2015) -
ADAM9 Up-Regulates N-Cadherin via miR-218 Suppression in Lung Adenocarcinoma Cells
por: Sher, Yuh-Pyng, et al.
Publicado: (2014)